Levonorgestrel butanoate: Difference between revisions
CSV import |
No edit summary |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 24: | Line 24: | ||
[[Category:Hormone therapy]] | [[Category:Hormone therapy]] | ||
[[Category:Drugs]] | [[Category:Drugs]] | ||
== Levonorgestrel_butanoate == | |||
<gallery> | |||
File:Levonorgestrel_butanoate.svg|Levonorgestrel butanoate chemical structure | |||
</gallery> | |||
Latest revision as of 00:34, 17 March 2025
Levonorgestrel Butanoate is a progestin medication which is used in birth control and hormone therapy. It is a long-acting, injectable form of levonorgestrel, a hormone that prevents ovulation and causes changes in the cervical mucus and uterine lining, making it harder for sperm to reach the uterus and harder for a fertilized egg to attach to the uterus.
Pharmacology[edit]
Levonorgestrel butanoate is a progestogen, or an agonist of the progesterone receptor, the biological target of progestogens like progesterone. It has weak androgenic and glucocorticoid activity and no other important hormonal activity.
Medical Uses[edit]
Levonorgestrel butanoate is used in birth control to prevent pregnancy. It is also used in hormone therapy for menopausal symptoms and in the treatment of gynecological disorders.
Side Effects[edit]
Common side effects of levonorgestrel butanoate include menstrual irregularities, headache, nausea, breast tenderness, and mood changes. Rare but serious side effects include blood clots, liver disease, and breast cancer.
History[edit]
Levonorgestrel butanoate was developed in the 1970s and 1980s and has been used in Europe and Asia for many years. It is not currently available in the United States or Canada.
See Also[edit]
Levonorgestrel_butanoate[edit]
-
Levonorgestrel butanoate chemical structure
